Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 0 | 1590 | 0 | 3 | 118 | 0.00 | 0.00 |  |
| 130 | Pharmaceutical Visions | journal | 0.100 Q4 | 2 | 0 | 125 | 0 | 2 | 67 | 0.03 | 0.00 | |
| 129 | Pharmacy in Practice | journal | 0.100 Q4 | 6 | 21 | 64 | 222 | 0 | 46 | 0.00 | 10.57 | |
| 128 | Quality Assurance Journal | journal | 0.100 Q4 | 11 | 29 | 60 | 72 | 1 | 51 | 0.02 | 2.48 | |
| 127 | European Journal of Herbal Medicine | journal | 0.102 Q4 | 3 | 6 | 14 | 68 | 1 | 9 | 0.07 | 11.33 | |
| 126 | Journal of Applied Therapeutic Research | journal | 0.108 Q4 | 8 | 0 | 28 | 0 | 3 | 28 | 0.00 | 0.00 | |
| 125 | Prescribers' Journal | journal | 0.108 Q4 | 6 | 0 | 73 | 0 | 7 | 56 | 0.03 | 0.00 | |
| 124 | Cutaneous and Ocular Toxicology | journal | 0.111 Q4 | 37 | 24 | 140 | 971 | 11 | 122 | 0.15 | 40.46 | |
| 123 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.112 Q4 | 8 | 0 | 49 | 0 | 4 | 47 | 0.08 | 0.00 | |
| 122 | Toxicology Mechanisms and Methods | journal | 0.121 Q4 | 55 | 23 | 98 | 679 | 45 | 96 | 0.39 | 29.52 | |
| 121 | Pharmaceutical News | journal | 0.125 Q3 | 11 | 66 | 101 | 1467 | 13 | 87 | 0.13 | 22.23 | |
| 120 | DARU, Journal of Pharmaceutical Sciences | journal | 0.155 Q3 | 58 | 33 | 28 | 582 | 4 | 28 | 0.14 | 17.64 | |
| 119 | Toxic Substance Mechanisms | journal | 0.159 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 118 | Pharmaceutical Medicine | journal | 0.162 Q3 | 25 | 30 | 203 | 405 | 38 | 130 | 0.17 | 13.50 | |
| 117 | IDrugs : the investigational drugs journal | journal | 0.172 Q3 | 39 | 177 | 306 | 2303 | 84 | 302 | 0.46 | 13.01 | |
| 116 | Drugs in R and D | journal | 0.176 Q3 | 54 | 89 | 240 | 1238 | 68 | 240 | 0.00 | 13.91 | |
| 115 | Toxicology Methods | journal | 0.186 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 114 | BMC Pharmacology | journal | 0.192 Q3 | 48 | 21 | 13 | 702 | 11 | 13 | 0.85 | 33.43 | |
| 113 | Paediatric and Perinatal Drug Therapy | journal | 0.193 Q3 | 20 | 13 | 45 | 427 | 17 | 39 | 0.34 | 32.85 | |
| 112 | Pharmacology Reviews and Communications | journal | 0.204 Q3 | 9 | 23 | 59 | 754 | 26 | 59 | 0.35 | 32.78 | |
| 111 | International Journal of Geriatric Psychopharmacology | journal | 0.208 Q3 | 11 | 0 | 29 | 0 | 12 | 28 | 0.44 | 0.00 | |
| 110 | Pharmaceutical Journal | journal | 0.208 Q2 | 28 | 2882 | 1642 | 1404 | 124 | 572 | 0.06 | 0.49 | |
| 109 | International Journal of Cosmetic Science | journal | 0.211 Q2 | 77 | 40 | 125 | 905 | 73 | 119 | 0.59 | 22.63 | |
| 108 | Comments on Toxicology | journal | 0.231 Q3 | 13 | 27 | 45 | 1001 | 17 | 33 | 0.60 | 37.07 | |
| 107 | Pharmacy and Pharmacology Communications | journal | 0.242 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 106 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.254 Q3 | 5 | 0 | 35 | 0 | 10 | 30 | 0.29 | 0.00 | |
| 105 | Pharmacology and Toxicology, Supplement | journal | 0.262 Q3 | 7 | 0 | 11 | 0 | 6 | 10 | 0.60 | 0.00 | |
| 104 | Expert Opinion on Emerging Drugs | journal | 0.270 Q3 | 54 | 25 | 68 | 2413 | 70 | 65 | 1.13 | 96.52 | |
| 103 | ATLA Alternatives to Laboratory Animals | journal | 0.271 Q3 | 65 | 105 | 213 | 2386 | 275 | 175 | 1.19 | 22.72 | |
| 102 | Journal of Asian Natural Products Research | journal | 0.272 Q2 | 51 | 49 | 112 | 529 | 43 | 112 | 0.43 | 10.80 | |
| 101 | Autonomic and Autacoid Pharmacology | journal | 0.281 Q3 | 24 | 35 | 0 | 1360 | 0 | 0 | 0.00 | 38.86 | |
| 100 | American Journal of PharmacoGenomics | journal | 0.286 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 99 | BMC Chemical Biology | journal | 0.293 Q4 | 21 | 1 | 4 | 30 | 4 | 4 | 1.00 | 30.00 | |
| 98 | International Antiviral News | journal | 0.295 Q3 | 8 | 0 | 75 | 0 | 36 | 52 | 0.73 | 0.00 | |
| 97 | Toxin Reviews | journal | 0.311 Q3 | 54 | 20 | 51 | 1741 | 54 | 47 | 0.78 | 87.05 | |
| 96 | Chemical Speciation and Bioavailability | journal | 0.313 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 95 | Biopharmaceutics and Drug Disposition | journal | 0.315 Q2 | 65 | 45 | 139 | 998 | 129 | 137 | 0.79 | 22.18 | |
| 94 | Toxicology in Vitro | journal | 0.320 Q3 | 125 | 93 | 267 | 3010 | 359 | 265 | 1.59 | 32.37 | |
| 93 | Pharmaceutical Biology | journal | 0.321 Q2 | 88 | 113 | 258 | 2868 | 106 | 257 | 0.31 | 25.38 | |
| 92 | Journal of Pharmacy and Pharmacology | journal | 0.325 Q2 | 137 | 206 | 1414 | 6631 | 1141 | 1402 | 0.84 | 32.19 | |
| 91 | BioDrugs | journal | 0.329 Q3 | 79 | 47 | 230 | 3842 | 264 | 217 | 1.44 | 81.74 | |
| 90 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.330 Q3 | 25 | 19 | 61 | 1078 | 53 | 29 | 0.65 | 56.74 | |
| 89 | Acta Pharmacologica Sinica | journal | 0.331 Q3 | 117 | 225 | 645 | 4294 | 502 | 644 | 0.73 | 19.08 | |
| 88 | Immunopharmacology and Immunotoxicology | journal | 0.336 Q3 | 61 | 45 | 149 | 1659 | 159 | 149 | 0.78 | 36.87 | |
| 87 | SAR and QSAR in Environmental Research | journal | 0.337 Q3 | 54 | 61 | 79 | 0 | 96 | 79 | 1.05 | 0.00 | |
| 86 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.338 Q3 | 67 | 67 | 185 | 1715 | 160 | 182 | 0.73 | 25.60 | |
| 85 | Fundamental and Clinical Pharmacology | journal | 0.340 Q3 | 85 | 57 | 183 | 1777 | 222 | 179 | 1.08 | 31.18 | |
| 84 | Drug Design and Discovery | journal | 0.344 Q3 | 20 | 4 | 55 | 48 | 49 | 50 | 0.88 | 12.00 | |
| 83 | ChemMedChem | journal | 0.346 Q2 | 119 | 139 | 399 | 3333 | 366 | 396 | 0.84 | 23.98 | |
| 82 | British Journal of Clinical Pharmacology, Supplement | journal | 0.350 Q2 | 33 | 9 | 19 | 145 | 27 | 17 | 1.42 | 16.11 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data